Miravo Healthcare has acquired 3 companies of its own, including 3 in the last 5 years. It has also divested 1 asset.
Miravo Healthcare’s largest acquisition to date was in 2018, when it acquired Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business for $110M. It’s largest disclosed sale occurred in 2014, when it sold Nuvo Research - PENNSAID to Horizon Therapeutics Public Limited Company for $45M. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Miravo Healthcare’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.
M&A Total Activity4
- M&A Buy Activity3
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1